[HTML][HTML] COVID-19 infection: the perspectives on immune responses

Y Shi, Y Wang, C Shao, J Huang, J Gan… - Cell Death & …, 2020 - nature.com
More than 100 years since the outbreak of the 1918 influenza pandemic, we now seem to
face another pandemic. The outbreak of the new coronavirus (SARS-CoV-2) infection is …

Immune response in COVID-19: What do we currently know?

DS Oliveira, NI Medeiros, JAS Gomes - Microbial pathogenesis, 2020 - Elsevier
In 2002/2003 there was a pandemic denominate SARS (severe acute respiratory
syndrome), caused by the SARS-CoV virus that belongs to the genera Betacoranavirus and …

[HTML][HTML] The immune response to SARS-CoV-2 and COVID-19 immunopathology–Current perspectives

JL Boechat, I Chora, A Morais, L Delgado - Pulmonology, 2021 - Elsevier
SARS-CoV-2 is a new beta coronavirus, similar to SARS-CoV-1, that emerged at the end of
2019 in the Hubei province of China. It is responsible for coronavirus disease 2019 (COVID …

Silent battles: immune responses in asymptomatic SARS-CoV-2 infection

N Le Bert, T Samandari - Cellular & Molecular Immunology, 2024 - nature.com
SARS-CoV-2 infections manifest with a broad spectrum of presentations, ranging from
asymptomatic infections to severe pneumonia and fatal outcomes. This review centers on …

Immune-epidemiological parameters of the novel coronavirus–a perspective

A Saghazadeh, N Rezaei - Expert review of clinical immunology, 2020 - Taylor & Francis
Introduction At the end of 2019, Wuhan, a city in China with a population of about 11 million,
witnessed the outbreak of unusual pneumonia. As of 29 March 2020, the disease has …

Immune response, inflammation, and the clinical spectrum of COVID-19

LF García - Frontiers in immunology, 2020 - frontiersin.org
The current COVID-19 pandemic began in December 2019 in Wuhan (China) and rapidly
extended to become a global sanitary and economic emergency. Its etiological agent is the …

Immune determinants of COVID-19 disease presentation and severity

P Brodin - Nature medicine, 2021 - nature.com
Abstract COVID-19, caused by SARS-CoV-2 infection, is mild to moderate in the majority of
previously healthy individuals, but can cause life-threatening disease or persistent …

COVID-19: an immunopathological view

K Kadkhoda - MSphere, 2020 - Am Soc Microbiol
Since its emergence in December 2019, it took only a couple of months for an outbreak of
the novel coronavirus disease 2019 (COVID-19) to be declared a pandemic by the World …

Dysregulation of the immune response affects the outcome of critical COVID‐19 patients

L Wei, W Wang, D Chen, B Xu - Journal of Medical Virology, 2020 - Wiley Online Library
Critical cases of coronavirus disease 2019 (COVID‐19) are associated with a high risk of
mortality. It remains unclear why patients with the same critical condition have different …

[HTML][HTML] Cellular immunity in COVID-19 convalescents with PCR-confirmed infection but with undetectable SARS-CoV-2–specific IgG

S Schwarzkopf, A Krawczyk, D Knop… - Emerging infectious …, 2021 - ncbi.nlm.nih.gov
We investigated immune responses against severe acute respiratory syndrome coronavirus
2 (SARS-CoV-2) among a group of convalescent, potential blood donors in Germany who …